Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding
Vivek Iyer(Johns Hopkins University), Karen L. Swanson(Mayo Clinic in Arizona), Aditya Kotecha(Mayo Clinic), Rajiv K. Pruthi(Mayo Clinic), Michael J. Krowka(Mayo Clinic), Erin K. O’Brien(Mayo Clinic in Arizona), Waleed Brinjikji(WinnMed), Darrell R. Schroeder(WinnMed), Hilary M. DuBrock(Mayo Clinic in Arizona), Dinesh Apala(Mayo Clinic), Kebede H. Begna(Mayo Clinic), Rodrigo Cartin‐Ceba, Bibek Pannu(Mayo Clinic), Michael D. Leise(Mayo Clinic in Arizona), Sanjay Misra(Mayo Clinic), Patrick S. Kamath(Mayo Clinic in Arizona)
Cited by 125
Related Papers
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
|Journal of the American College of Cardiology|2017|1.9k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global burden of liver disease: 2023 update
|Journal of Hepatology|2023|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
|New England Journal of Medicine|2008|1.5k